Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models

Study acronym: MAPS-LLM
StatusUnknown
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Primary endpoint revised
    • Interventions: Manual clinical trial screning by study staff (Other), RECTIFIER - a generative artificial intelligence screening tool (Other) to Manual clinical trial screening by study staff (Other), RECTIFIER - a generative artificial intelligence screening tool (Other)
    • Secondary endpoint revised
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective randomized controlled trial comparing manual review and AI screening for patient eligibility determination and enrollments. A structured query will identify potentially eligible patients from the Mass General Brigham Electronic Data Warehouse (EDW), who will then be randomized into either the manual review arm or the AI-assisted review arm.
Trial Details
NCT Number NCT06588452
Lead Sponsor Brigham and Women's Hospital
Conditions
(from sponsor)		 Comparing Manual and AI Patient Screening in Heart Failure
Enrollment 4,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov